LRRK2 and Parkinson disease: In our previous studies, mutations in the LRRK2 and GBA genes were detected in a surprisingly high proportion (more than a third) of the Ashkenazi PD-patients tested [14,15], allowing the sub-classification of these patients based on their LRRK2 or GBA carrier status.